India Biologics Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Growth Rate: 8.0% (2025-2033)

Market Size in 2024: USD 12.3 Billion

Market Size in 2033: USD 24.6 Billion

The India biologics market is growing rapidly, driven by advancements in biotechnology, increasing healthcare demands, and rising chronic diseases. According to the latest report by IMARC Group, the market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.6 Billion by 2033, exhibiting a growth rate (CAGR) of 8.0% during 2025-2033.

India Biologics Market Trends and Drivers:

The India biologics market is expanding rapidly, owing to several interconnected factors. Primarily, the market is driven by the growing incidence of chronic illnesses, rising healthcare costs as well as the advancements in biotechnology. Meanwhile, biologics are becoming more popular because of their capacity to cure complicated illnesses including diabetes, autoimmune diseases, and cancer, where conventional drugs frequently fail.

Furthermore, India’s large and diverse population, with a growing number of patients seeking innovative treatments, is driving the demand of the India biologics market. In addition to this, the initiatives of several government bodies, like the National Biotechnology Development Strategy and favorable policies promoting biotechnology research and development, are also accelerating the expansion of the biologics sector.

Another significant trend in the India biologics market is the rising prominence of biosimilars. With the expiration of patents for several blockbuster biologic drugs, the market for biosimilars, which are more affordable alternatives to branded biologics, is gaining momentum. Indian pharmaceutical companies are increasingly focusing on developing and manufacturing biosimilars to meet the growing demand for cost-effective biologic therapies, both in domestic and international markets. Additionally, the market is also witnessing advancements in personalized medicine and gene therapies, which promise to revolutionize the treatment landscape.

Moreover, India’s well-established manufacturing capabilities and its position as a global hub for affordable biologic production are further strengthening its role in the global biologics market. As the healthcare infrastructure continues to improve and research and development activities intensify, the India biologics market is expected to expand significantly in the coming years.

Request for a sample copy of this report: https://www.imarcgroup.com/india-biologics-market/requestsample

India Biologics Market Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Source:

• Microbial
• Mammalian
• Others

Breakup by Product:

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others

Breakup by Disease:

• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

Breakup by Manufacturing:

• Outsourced
• In-House

Breakup by Region:

• North India
• West and Central India
• South India
• East and Northeast India

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=21849&flag=C

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

• Uncategorized